Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Biopsy is a procedure of removing of a small amount of tissue for examination under a microscope. Imaging tests may suggest the diagnosis of sarcoma, but biopsy is performed to confirm the diagnosis and to find out the type of sarcoma. Several types of biopsies are used to diagnose sarcomas and most biopsies are needle biopsies, in which needle is used to access the suspicious tissue of sarcoma.
The global sarcoma biopsy market was valued at US$ 197.94 million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).
Fig1. Global Sarcoma Biopsy Market Share (%) Analysis, By Product Type, 2019
Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.
Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.
There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.
Global Sarcoma Biopsy Market– Regional Analysis
North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.
Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.
Fig.2 Global Sarcoma Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Global Sarcoma Biopsy Market- Competitive Landscape
Key players operating in the global sarcoma biopsy market include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab